{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:33:40Z","timestamp":1787067220459,"version":"build-2736575974"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.cct.2022.106784","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T11:44:42Z","timestamp":1653306282000},"page":"106784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Analysis of female enrollment in clinical trials for alcohol and substance use disorders: Is it time for sex-informed pharmacotherapy?"],"prefix":"10.1016","volume":"118","author":[{"given":"Chiara","family":"Montemitro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Cavallotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Giovannetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Pasino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Vicinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Fraticelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Di Giannantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Primavera A.","family":"Spagnolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2022.106784_bb0005","author":"U.S. Department of Health and Human Services SAaMHSA, Center for Behavioral Health Statistics and Quality"},{"key":"10.1016\/j.cct.2022.106784_bb0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.drugalcdep.2007.08.017","article-title":"Evidence for a closing gender gap in alcohol use, abuse, and dependence in the United States population","volume":"93","author":"Keyes","year":"2008","journal-title":"Drug Alcohol Depend."},{"issue":"7","key":"10.1016\/j.cct.2022.106784_bb0015","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/archgenpsychiatry.2009.36","article-title":"Cross-national associations between gender and mental disorders in the World Health Organization world mental health surveys","volume":"66","author":"Seedat","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"issue":"9","key":"10.1016\/j.cct.2022.106784_bb0020","first-page":"1712","article-title":"Converging patterns of alcohol use and related outcomes among females and males in the United States, 2002 to 2012","volume":"39","author":"White","year":"2015"},{"key":"10.1016\/j.cct.2022.106784_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2019.100149","article-title":"Sex differences in stress-related alcohol use","volume":"10","author":"Peltier","year":"2019","journal-title":"Neurobiol. Stress."},{"key":"10.1016\/j.cct.2022.106784_bb0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.annepidem.2021.06.004","article-title":"US trends in binge drinking by gender, occupation, prestige, and work structure among adults in the midlife, 2006\u20132018","volume":"62","author":"McKetta","year":"2021","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.cct.2022.106784_bb0035","doi-asserted-by":"crossref","first-page":"108026","DOI":"10.1016\/j.drugalcdep.2020.108026","article-title":"Trends in U.S. women\u2019s binge drinking in middle adulthood by socioeconomic status, 2006\u20132018","volume":"212","author":"McKetta","year":"2020","journal-title":"Drug Alcohol Depend."},{"issue":"10","key":"10.1016\/j.cct.2022.106784_bb0040","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011827","article-title":"Birth cohort trends in the global epidemiology of alcohol use and alcohol-related harms in men and women: systematic review and metaregression","volume":"6","author":"Slade","year":"2016","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.cct.2022.106784_bb0045","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1001\/jamapsychiatry.2017.2161","article-title":"Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001-2002 to 2012-2013: results from the National Epidemiologic Survey on alcohol and related conditions","volume":"74","author":"Grant","year":"2017","journal-title":"JAMA Psychiatry."},{"key":"10.1016\/j.cct.2022.106784_bb0050","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2017 National Survey on Drug Use and Health","author":"U.S. Department of Health and Human Services SAaMHSA","year":"2018"},{"issue":"3","key":"10.1016\/j.cct.2022.106784_bb0055","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.drugalcdep.2004.02.001","article-title":"Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment","volume":"74","author":"Hernandez-Avila","year":"2004","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"10.1016\/j.cct.2022.106784_bb0060","first-page":"300","article-title":"Gender differences in treatment-seeking cocaine abusers\u2014implications for treatment and prognosis","volume":"8","author":"McCance-Katz","year":"1999"},{"issue":"4","key":"10.1016\/j.cct.2022.106784_bb0065","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1081\/ADA-100101893","article-title":"Course, severity, and treatment of substance abuse among women versus men","volume":"26","author":"Westermeyer","year":"2000","journal-title":"Am. J. Drug Alcohol Abuse."},{"issue":"1\u20132","key":"10.1016\/j.cct.2022.106784_bb0070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/00952998709001500","article-title":"Sex differences in addict careers. 2. Becoming addicted","volume":"13","author":"Anglin","year":"1987","journal-title":"Am. J. Drug Alcohol Abuse."},{"issue":"11","key":"10.1016\/j.cct.2022.106784_bb0075","first-page":"1707","article-title":"Gender differences in substance use disorders","volume":"150","author":"Brady","year":"1993"},{"issue":"1","key":"10.1016\/j.cct.2022.106784_bb0080","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2042-6410-3-14","article-title":"Sex differences in the neural mechanisms mediating addiction: a new synthesis and hypothesis","volume":"3","author":"Becker","year":"2012","journal-title":"Biol. Sex Differ."},{"issue":"3","key":"10.1016\/j.cct.2022.106784_bb0085","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.neubiorev.2010.05.001","article-title":"Ovarian hormones and propensity to drug relapse: A review","volume":"35","author":"Hudson","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"10250","key":"10.1016\/j.cct.2022.106784_bb0090","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)31561-0","article-title":"Sex and gender: modifiers of health, disease, and medicine","volume":"396","author":"Mauvais-Jarvis","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cct.2022.106784_bb0095","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.neubiorev.2010.07.002","article-title":"Sex bias in neuroscience and biomedical research","volume":"35","author":"Beery","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.cct.2022.106784_bb0100","doi-asserted-by":"crossref","first-page":"708","DOI":"10.18549\/PharmPract.2016.01.708","article-title":"Women\u2019s involvement in clinical trials: historical perspective and future implications","volume":"14","author":"Liu","year":"2016","journal-title":"Pharm. Pract. (Granada)."},{"issue":"2","key":"10.1016\/j.cct.2022.106784_bb0105","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.phrs.2006.11.001","article-title":"Gender differences in drug responses","volume":"55","author":"Franconi","year":"2007","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.cct.2022.106784_bb0110","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1586\/ecp.11.29","article-title":"Adverse effects in women: implications for drug development and regulatory policies","volume":"4","author":"Parekh","year":"2011","journal-title":"Expert. Rev. Clin. Pharmacol."},{"issue":"18","key":"10.1016\/j.cct.2022.106784_bb0115","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1001\/jama.2016.16405","article-title":"Reporting sex, gender, or both in clinical research?","volume":"316","author":"Clayton","year":"2016","journal-title":"JAMA."},{"issue":"1","key":"10.1016\/j.cct.2022.106784_bb0120","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41073-016-0007-6","article-title":"Sex and gender equity in research: rationale for the SAGER guidelines and recommended use","volume":"1","author":"Heidari","year":"2016","journal-title":"Res. Integr. Peer Rev."},{"key":"10.1016\/j.cct.2022.106784_bb0125","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"Association","year":"2000"},{"key":"10.1016\/j.cct.2022.106784_bb0130","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"Association","year":"2013"},{"issue":"2","key":"10.1016\/j.cct.2022.106784_bb0135","first-page":"101","article-title":"Abstinence and reduced frequency of use are associated with improvements in quality of life among treatment-seekers with cannabis use disorder","volume":"27","author":"Brezing","year":"2018"},{"issue":"11","key":"10.1016\/j.cct.2022.106784_bb0140","first-page":"1199","article-title":"Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm","volume":"171","author":"Rose","year":"2014"},{"issue":"9","key":"10.1016\/j.cct.2022.106784_bb0145","first-page":"1773","article-title":"Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers","volume":"23","author":"Chenoweth","year":"2014"},{"issue":"2","key":"10.1016\/j.cct.2022.106784_bb0150","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00213-019-05384-z","article-title":"Depressive symptoms and cannabis use in a placebo-controlled trial of N-acetylcysteine for adult cannabis use disorder","volume":"237","author":"Tomko","year":"2020","journal-title":"Psychopharmacology."},{"issue":"25U","key":"10.1016\/j.cct.2022.106784_bb0155","first-page":"264","article-title":"Pain-related anxiety as a predictor of early lapse and relapse to cigarette smoking","volume":"25","author":"LaRowe","year":"2017"},{"issue":"3","key":"10.1016\/j.cct.2022.106784_bb0160","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1017\/jsc.2020.13","article-title":"An integrated behavioural intervention combined with varenicline for heavy-drinking smokers: a randomized pilot study","volume":"15","author":"Fucito","year":"2020","journal-title":"J. Smok. Cessat."},{"key":"10.1016\/j.cct.2022.106784_bb0165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jsat.2017.07.012","article-title":"Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life","volume":"81","author":"Hser","year":"2017","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.cct.2022.106784_bb0170","series-title":"A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults","author":"Gray","year":"2019"},{"issue":"9","key":"10.1016\/j.cct.2022.106784_bb0175","first-page":"1660","article-title":"Failure to improve cigarette smoking abstinence with transdermal selegiline+cognitive behavior therapy","volume":"105","author":"Killen","year":"2010"},{"key":"10.1016\/j.cct.2022.106784_bb0180","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.13m08862","article-title":"Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence","volume":"75","author":"Winhusen","year":"2014","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.cct.2022.106784_bb0185","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cct.2014.08.011","article-title":"Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network","volume":"39","author":"McClure","year":"2014","journal-title":"Contemp. Clin. Trials."},{"issue":"5","key":"10.1016\/j.cct.2022.106784_bb0190","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/ntr\/ntv236","article-title":"Zonisamide reduces withdrawal symptoms but does not enhance varenicline-induced smoking cessation","volume":"18","author":"Dunn","year":"2015","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.cct.2022.106784_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108366","article-title":"Quetiapine treatment for cannabis use disorder","volume":"218","author":"Mariani","year":"2021","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.cct.2022.106784_bb0200","first-page":"561","article-title":"A randomized controlled trial of 24 weeks of varenicline for tobacco use among cancer patients: efficacy, safety, and adherence","volume":"28","author":"Schnoll","year":"2019"},{"key":"10.1016\/j.cct.2022.106784_bb0205","series-title":"The effects of subanesthetic ketamine infusions on motivation to quit and cue-induced craving in cocaine-dependent research volunteers","author":"Dakwar","year":"2014"},{"key":"10.1016\/j.cct.2022.106784_bb0210","doi-asserted-by":"crossref","first-page":"157","DOI":"10.15288\/jsas.2005.s15.157","article-title":"The COMBINE SAFTEE: a structured instrument for collecting adverse events adapted for clinical studies in the alcoholism field","author":"Johnson","year":"2005","journal-title":"J. Stud. Alcohol Suppl."},{"key":"10.1016\/j.cct.2022.106784_bb0215","series-title":"Psychiatric Disorders in America: The Epidemiological Catchment Area Study","first-page":"81","article-title":"Alcohol abuse and dependence","author":"Helzer","year":"1991"},{"key":"10.1016\/j.cct.2022.106784_bb0220","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1001\/archpsyc.64.7.830","article-title":"Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on alcohol and related conditions","volume":"64","author":"Hasin","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.cct.2022.106784_bb0225","first-page":"976","article-title":"Trends in alcohol consumption among older Americans: National health interview surveys, 1997 to 2014","volume":"41","author":"Breslow","year":"2017"},{"issue":"2","key":"10.1016\/j.cct.2022.106784_bb0230","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0193-953X(05)70074-5","article-title":"Gender differences in substance use disorders","volume":"22","author":"Brady","year":"1999","journal-title":"Psychiatr. Clin. N. Am."},{"key":"10.1016\/j.cct.2022.106784_bb0235","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cpr.2017.10.012","article-title":"Sex and gender differences in substance use disorders","volume":"66","author":"McHugh","year":"2018","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.cct.2022.106784_bb0240","series-title":"Deaths: Leading Causes for 2017","author":"Heron","year":"2019"},{"issue":"7","key":"10.1016\/j.cct.2022.106784_bb0245","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1111\/add.15333","article-title":"A US national randomized study to guide how best to reduce stigma when describing drug-related impairment in practice and policy","volume":"116","author":"Kelly","year":"2021","journal-title":"Addiction."},{"key":"10.1016\/j.cct.2022.106784_bb0250","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/02791072.1997.10400171","article-title":"Services for perinatal women with substance abuse and mental health disorders: the unmet need","volume":"29","author":"Grella","year":"1997","journal-title":"J. Psychoactive Drugs"},{"issue":"1","key":"10.1016\/j.cct.2022.106784_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2006.05.012","article-title":"Substance abuse treatment entry, retention, and outcome in women: a review of the literature","volume":"86","author":"Greenfield","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.cct.2022.106784_bb0260","series-title":"Assessing Stigma Towards Substance Use in Pregnancy: A Randomized Study Testing the Impact of Stigmatizing Language and Type of Opioid Use on Attitudes Toward Mothers with Opioid Use Disorder","volume":"9000","author":"Schiff","year":"2021"},{"issue":"3","key":"10.1016\/j.cct.2022.106784_bb0265","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41386-020-00915-1","article-title":"Sex differences in dopamine release regulation in the striatum","volume":"46","author":"Zachry","year":"2021","journal-title":"Neuropsychopharmacology."},{"key":"10.1016\/j.cct.2022.106784_bb0270","article-title":"Making pharmaceutical research and regulation work for women","volume":"371","author":"Ravindran","year":"2020","journal-title":"BMJ."},{"issue":"1","key":"10.1016\/j.cct.2022.106784_bb0275","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1076-7460.2004.01709.x","article-title":"Willingness to participate in cardiac trials","volume":"13","author":"Peterson","year":"2004","journal-title":"Am. J. Geriatr. Cardiol."},{"issue":"1","key":"10.1016\/j.cct.2022.106784_bb0280","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/0963721411429452","article-title":"Risk and reward are processed differently in decisions made under stress","volume":"21","author":"Mather","year":"2012","journal-title":"Curr. Dir. Psychol. Sci."},{"key":"10.1016\/j.cct.2022.106784_bb0285","series-title":"Exploring the Biological Contributions to Human Health: Does Sex Matter? Wizemann TM, Pardue M-L, Editors","first-page":"288","author":"Medicine Io","year":"2001"},{"key":"10.1016\/j.cct.2022.106784_bb0290","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.drugalcdep.2014.10.007","article-title":"Gender differences in clinical outcomes for cocaine dependence: randomized clinical trials of behavioral therapy and disulfiram","volume":"145","author":"DeVito","year":"2014","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.cct.2022.106784_bb0295","first-page":"273","article-title":"Sex differences in smoking cessation pharmacotherapy comparative efficacy: a network Meta-analysis","volume":"19","author":"Smith","year":"2017","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.cct.2022.106784_bb0300","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.drugalcdep.2019.02.007","article-title":"A systematic review of sex differences in treatment outcomes among people with opioid use disorder receiving buprenorphine maintenance versus other treatment conditions","volume":"197","author":"Ling","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.cct.2022.106784_bb0305","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.56344","article-title":"A 10-year follow-up study of sex inclusion in the biological sciences","volume":"9","author":"Woitowich","year":"2020","journal-title":"eLife."},{"issue":"5","key":"10.1016\/j.cct.2022.106784_bb0310","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S2215-0366(14)70333-5","article-title":"Progesterone for the reduction of cocaine use in post-partum women with a cocaine use disorder: a randomised, double-blind, placebo-controlled, pilot study","volume":"1","author":"Yonkers","year":"2014","journal-title":"Lancet Psychiatry"},{"issue":"11","key":"10.1016\/j.cct.2022.106784_bb0315","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/ntr\/ntw156","article-title":"Progesterone and postpartum smoking relapse: A pilot double-blind placebo-controlled randomized trial","volume":"18","author":"Allen","year":"2016","journal-title":"Nicotine Tob. Res."},{"issue":"9","key":"10.1016\/j.cct.2022.106784_bb0320","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.psyneuen.2012.12.022","article-title":"The effects of exogenous progesterone on drug craving and stress arousal in cocaine dependence: impact of gender and cue type","volume":"38","author":"Fox","year":"2013","journal-title":"Psychoneuroendocrinology."},{"key":"10.1016\/j.cct.2022.106784_bb0325","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.psyneuen.2015.12.008","article-title":"Effects of progesterone stimulated allopregnanolone on craving and stress response in cocaine dependent men and women","volume":"65","author":"Milivojevic","year":"2016","journal-title":"Psychoneuroendocrinology."},{"key":"10.1016\/j.cct.2022.106784_bb0330","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.brainres.2009.12.093","article-title":"The effect of estrogen on dopamine and serotonin receptor and transporter levels in the brain: an autoradiography study","volume":"1321","author":"Chavez","year":"2010","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.cct.2022.106784_bb0335","first-page":"155","article-title":"Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines","volume":"62","author":"Gillies","year":"2010"},{"issue":"1","key":"10.1016\/j.cct.2022.106784_bb0340","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00213-008-1371-9","article-title":"Effects of allopregnanolone on the reinstatement of cocaine-seeking behavior in male and female rats","volume":"203","author":"Anker","year":"2009","journal-title":"Psychopharmacology."},{"key":"10.1016\/j.cct.2022.106784_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2019.100789","article-title":"Stress and drug abuse-related disorders: the promising therapeutic value of neurosteroids focus on pregnenolone-progesterone-allopregnanolone pathway","volume":"55","author":"Tomaselli","year":"2019","journal-title":"Front. Neuroendocrinol."},{"issue":"2","key":"10.1016\/j.cct.2022.106784_bb0350","first-page":"320","article-title":"A rationale for allopregnanolone treatment of alcohol use disorders: basic and clinical studies","volume":"44","author":"Morrow","year":"2020"},{"issue":"2","key":"10.1016\/j.cct.2022.106784_bb0355","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.36512","article-title":"Prevalence and co-occurrence of alcohol, nicotine, and other substance use disorder diagnoses among US transgender and cisgender adults","volume":"4","author":"Hughto","year":"2021","journal-title":"JAMA Netw. Open"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714422001100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714422001100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:56:17Z","timestamp":1761555377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714422001100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":71,"alternative-id":["S1551714422001100"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2022.106784","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of female enrollment in clinical trials for alcohol and substance use disorders: Is it time for sex-informed pharmacotherapy?","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2022.106784","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106784"}}